Live Breaking News & Updates on Eyepoint Pharmaceuticals Daily

Stay updated with breaking news from Eyepoint pharmaceuticals daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Monashee Investment Management LLC Takes $4.04 Million Position in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT)

Monashee Investment Management LLC bought a new stake in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 175,000 shares of the company’s stock, valued at approximately $4,044,000. EyePoint Pharmaceuticals accounts for about 0.7% of Monashee […] ....

Robertw Baird , Davidr Guyer , Securities Exchange Commission , Quarter For Eyepoint Pharmaceuticals , Investment Advisers , Deutsche Bank , Eyepoint Pharmaceuticals Company Profile , China Universal Asset Management Co , Eyepoint Pharmaceuticals , Eyepoint Pharmaceuticals Inc , Mirae Asset Global Investments Co , News Ratings For Eyepoint Pharmaceuticals Daily , Monashee Investment Management , Eyepoint Pharmaceuticals Stock Performance , Toth Financial Advisory Corp , Insider Activity At Eyepoint Pharmaceuticals , Free Report , Point Pharmaceuticals , Investment Management , Asset Global Investments , Financial Advisory Corp , China Universal Asset Management , Director David , Exchange Commission , Cormorant Asset Management , One Financial ,

EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Down to $11.16

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report)’s stock price gapped down prior to trading on Tuesday . The stock had previously closed at $11.16, but opened at $10.90. EyePoint Pharmaceuticals shares last traded at $11.13, with a volume of 79,034 shares. Analyst Ratings Changes Several research analysts have recently issued reports on the company. […] ....

Davidr Guyer , Robertw Baird , Institutional Trading Of Eyepoint Pharmaceuticals , Securities Exchange Commission , Eyepoint Pharmaceuticals Inc , Eyepoint Pharmaceuticals Company Profile , Mirae Asset Global Investments Co , Eyepoint Pharmaceuticals Stock , News Ratings For Eyepoint Pharmaceuticals Daily , Deutsche Bank , Investment Advisers , Eyepoint Pharmaceuticals , Tower Research Capital , Ameritas Investment Partners Inc , Get Free Report , Point Pharmaceuticals , One Financial , Director David , Cormorant Asset Management , Exchange Commission , Asset Global Investments , Investment Partners , Research Capital , Eyepoint Pharmaceuticals Daily ,

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives Consensus Recommendation of "Buy" from Analysts

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives Consensus Recommendation of "Buy" from Analysts
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Robertw Baird , York Mellon Corp , Eyepoint Pharmaceuticals Company Profile , Securities Exchange Commission , Eyepoint Pharmaceuticals Stock , Jpmorgan Chase Co , Analyst Recommendations For Eyepoint Pharmaceuticals , Insider Activity At Eyepoint Pharmaceuticals , Eyepoint Pharmaceuticals Inc , Eyepoint Pharmaceuticals , Hedge Funds Weigh In On Eyepoint Pharmaceuticals , Mirae Asset Global Investments Co , News Ratings For Eyepoint Pharmaceuticals Daily , Jump Financial , Td Asset Management Inc , Get Free Report , Marketbeat Ratings , Point Pharmaceuticals , Cormorant Asset Management , Exchange Commission , New York Mellon Corp , Asset Global Investments , Management Inc , Get Free , Eyepoint Pharmaceuticals Daily ,

Analysts Set EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Target Price at $34.00

Analysts Set EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Target Price at $34.00
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Securities Exchange Commission , Hermes Inc , Insider Activity At Eyepoint Pharmaceuticals , Eyepoint Pharmaceuticals Inc , Franklin Resources Inc , Analyst Recommendations For Eyepoint Pharmaceuticals , Eyepoint Pharmaceuticals Price Performance , News Ratings For Eyepoint Pharmaceuticals Daily , Jennison Associates , Jpmorgan Chase Co , Eyepoint Pharmaceuticals Company Profile , Vanguard Group Inc , Institutional Investors Weigh In On Eyepoint Pharmaceuticals , Eyepoint Pharmaceuticals , Get Free Report , One Financial , Cormorant Asset Management , Exchange Commission , Vanguard Group , Point Pharmaceuticals , Get Free , Eyepoint Pharmaceuticals Daily ,

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Given Consensus Recommendation of "Buy" by Analysts

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Given Consensus Recommendation of "Buy" by Analysts
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Robertw Baird , China Universal Asset Management Co , Eyepoint Pharmaceuticals , News Ratings For Eyepoint Pharmaceuticals Daily , Jpmorgan Chase Co , Eyepoint Pharmaceuticals Inc , Tower Research Capital , Analyst Recommendations For Eyepoint Pharmaceuticals , Sherbrooke Park Advisers , Investment Advisers , Eyepoint Pharmaceuticals Price Performance , Toth Financial Advisory Corp , Get Free Report , One Financial , Cormorant Asset Management , Universal Asset Management , Park Advisers , Research Capital , Financial Advisory Corp , Point Pharmaceuticals , Get Free , Eyepoint Pharmaceuticals Daily ,